These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29187672)

  • 1. Clinical Characteristics and Low Susceptibility to Daptomycin in Enterococcus faecium Bacteremia.
    Namikawa H; Yamada K; Shibata W; Fujimoto H; Takizawa E; Niki M; Nakaie K; Nakamura Y; Oinuma KI; Niki M; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
    Tohoku J Exp Med; 2017 Nov; 243(3):211-218. PubMed ID: 29187672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
    Shukla BS; Shelburne S; Reyes K; Kamboj M; Lewis JD; Rincon SL; Reyes J; Carvajal LP; Panesso D; Sifri CD; Zervos MJ; Pamer EG; Tran TT; Adachi J; Munita JM; Hasbun R; Arias CA
    Clin Infect Dis; 2016 Jun; 62(12):1514-1520. PubMed ID: 27045126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Kidd JM; Abdelraouf K; Asempa TE; Humphries RM; Nicolau DP
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis.
    Egli A; Schmid H; Kuenzli E; Widmer AF; Battegay M; Plagge H; Frei R; Achermann R; Weisser M
    Clin Microbiol Infect; 2017 Feb; 23(2):118.e1-118.e7. PubMed ID: 27746397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.
    Munita JM; Mishra NN; Alvarez D; Tran TT; Diaz L; Panesso D; Reyes J; Murray BE; Adachi JA; Bayer AS; Arias CA
    Clin Infect Dis; 2014 Nov; 59(9):1277-80. PubMed ID: 25107294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.
    DiPippo AJ; Tverdek FP; Tarrand JJ; Munita JM; Tran TT; Arias CA; Shelburne SA; Aitken SL
    J Infect; 2017 Mar; 74(3):243-247. PubMed ID: 27845153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin for highly resistant Enterococcus faecium infection.
    Rosin C; Bernsmeier C; Entenza JM; Moreillon P; Frei R; Weisser M; Flückiger U
    Swiss Med Wkly; 2012; 142():w13603. PubMed ID: 22736040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
    Menon V; Davis R; Shackel N; Espedido BA; Beukers AG; Jensen SO; van Hal SJ
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):120-122. PubMed ID: 29195768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline.
    Polidori M; Nuccorini A; Tascini C; Gemignani G; Iapoce R; Leonildi A; Tagliaferri E; Menichetti F
    J Chemother; 2011 Aug; 23(4):240-1. PubMed ID: 21803704
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Britt NS; Potter EM; Patel N; Steed ME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
    Cunha BA; Mickail N; Eisenstein L
    Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection.
    Alder J; Li T; Yu D; Morton L; Silverman J; Zhang XX; Critchley I; Thorne G
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3561-6. PubMed ID: 14576118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
    Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
    Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.
    Kinnear CL; Patel TS; Young CL; Marshall V; Newton DW; Read AF; Woods RJ
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.
    Woods RJ; Patel TS; Nagel JL; Newton DW; Read AF
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):226-228. PubMed ID: 29331166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.